Login / Signup

Adverse Events Induced by PD-1/PD-L1 Inhibitors: A Real-World Single-Centre Experience with a Management-Based Approach.

Fabien GrimaudGuillaume PénarandaChloé StavrisFrédérique RetornazVéronique BrunelSylvie CailleresHervé PegliascoJacques Le TreutVincent GrisoniEmilie CoquetLaurent ChicheAmélie Rognon
Published in: Therapeutics and clinical risk management (2021)
PD-1 and PD-L1 inhibitors are effective and safe in a real-world setting. Implementation of a standardised management-based protocol with internal medicine specialists is an effective way to optimise irAE management.
Keyphrases
  • primary care
  • healthcare
  • randomized controlled trial